CME Group Statistics
Share Statistics
CME Group has 360.36M shares outstanding. The number of shares has increased by 0.03% in one year.
Shares Outstanding | 360.36M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.01% |
Owned by Institutions (%) | n/a |
Shares Floating | 359.18M |
Failed to Deliver (FTD) Shares | 5.80K |
FTD / Avg. Volume | 0.29% |
Short Selling Information
The latest short interest is 3.83M, so 1.06% of the outstanding shares have been sold short.
Short Interest | 3.83M |
Short % of Shares Out | 1.06% |
Short % of Float | 1.07% |
Short Ratio (days to cover) | 2.39 |
Valuation Ratios
The PE ratio is 23.44 and the forward PE ratio is 21.82. CME Group 's PEG ratio is 1.41.
PE Ratio | 23.44 |
Forward PE | 21.82 |
PS Ratio | 13.55 |
Forward PS | 13.7 |
PB Ratio | 2.83 |
P/FCF Ratio | 22.39 |
PEG Ratio | 1.41 |
Enterprise Valuation
CME Group Inc. has an Enterprise Value (EV) of 76.58B.
EV / Earnings | 23.74 |
EV / Sales | 13.73 |
EV / EBITDA | 20.21 |
EV / EBIT | 22.29 |
EV / FCF | 22.67 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.13.
Current Ratio | 1.02 |
Quick Ratio | 1.02 |
Debt / Equity | 0.13 |
Total Debt / Capitalization | 11.36 |
Cash Flow / Debt | 1.01 |
Interest Coverage | 21.55 |
Financial Efficiency
Return on equity (ROE) is 0.12% and return on capital (ROIC) is 8.71%.
Return on Equity (ROE) | 0.12% |
Return on Assets (ROA) | 0.02% |
Return on Capital (ROIC) | 8.71% |
Revenue Per Employee | 1.56M |
Profits Per Employee | 904.96K |
Employee Count | 3.56K |
Asset Turnover | 0.04 |
Inventory Turnover | 0 |
Taxes
Income Tax | 927.40M |
Effective Tax Rate | 0.22 |
Stock Price Statistics
The stock price has increased by 14.76% in the last 52 weeks. The beta is 0.56, so CME Group 's price volatility has been higher than the market average.
Beta | 0.56 |
52-Week Price Change | 14.76% |
50-Day Moving Average | 228.66 |
200-Day Moving Average | 213.49 |
Relative Strength Index (RSI) | 53.98 |
Average Volume (20 Days) | 2.01M |
Income Statement
In the last 12 months, CME Group had revenue of $5.58B and earned $3.23B in profits. Earnings per share was $8.87.
Revenue | 5.58B |
Gross Profit | 4.54B |
Operating Income | 3.44B |
Net Income | 3.23B |
EBITDA | 3.79B |
EBIT | 3.44B |
Earnings Per Share (EPS) | 8.87 |
Balance Sheet
The company has $2.91B in cash and $3.88B in debt, giving a net cash position of -$971.90M.
Cash & Cash Equivalents | 2.91B |
Total Debt | 3.88B |
Net Cash | -971.90M |
Retained Earnings | 4.46B |
Total Assets | 137.80B |
Working Capital | 2.32B |
Cash Flow
In the last 12 months, operating cash flow was $3.45B and capital expenditures -$76.40M, giving a free cash flow of $3.38B.
Operating Cash Flow | 3.45B |
Capital Expenditures | -76.40M |
Free Cash Flow | 3.38B |
FCF Per Share | 9.41 |
Margins
Gross margin is 81.39%, with operating and profit margins of 61.58% and 57.83%.
Gross Margin | 81.39% |
Operating Margin | 61.58% |
Pretax Margin | 74.45% |
Profit Margin | 57.83% |
EBITDA Margin | 67.9% |
EBIT Margin | 61.58% |
FCF Margin | 60.54% |
Dividends & Yields
CME pays an annual dividend of $5.75, which amounts to a dividend yield of 2.44%.
Dividend Per Share | $5.75 |
Dividend Yield | 2.44% |
Dividend Growth (YoY) | -78.1% |
Payout Ratio | 60.46% |
Earnings Yield | 3.74% |
FCF Yield | 3.95% |
Analyst Forecast
The average price target for CME is $233, which is -1.8% lower than the current price. The consensus rating is "Hold".
Price Target | $233 |
Price Target Difference | -1.8% |
Analyst Consensus | Hold |
Analyst Count | 15 |
Stock Splits
The last stock split was on Jul 23, 2012. It was a forward split with a ratio of 5:1.
Last Split Date | Jul 23, 2012 |
Split Type | forward |
Split Ratio | 5:1 |
Scores
Altman Z-Score | 0.68 |
Piotroski F-Score | 7 |